Request Free Sample
×
UK Biomarker Technologies Market
ID: MRFR/HC/54481-HCR
200 Pages
June 2025
UK Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035
Industry Developments
Recent developments in the UK Biomarker Technologies Market have been significant, particularly with major players such as Agilent Technologies, Abbott Laboratories, and Roche focusing on advancing their product lines. Notably, Thermo Fisher Scientific launched a new liquid biopsy test in September 2023 aimed at early cancer detection, which is anticipated to bolster their market position. Additionally, PerkinElmer expanded its capabilities in genomics through a collaboration with QIAGEN in August 2023, enhancing the development of diagnostic solutions in the UK.In terms of mergers and acquisitions, Bristol-Myers Squibb acquired a prominent biotechnology firm specializing in biomarkers in October 2023, which is expected to improve its research pipeline significantly. This move aligns with the growing demand for targeted therapies in the UK market. Furthermore, the overall market valuation of companies like Amgen and BioRad Laboratories has seen a positive trend, largely driven by increased R&D investments in biomarker discovery and diagnostic technologies, showing a robust compound annual growth rate in the last two years. UK governmental initiatives supporting innovative biomedical research continue to play a crucial role in energizing the biomarker landscape and fostering growth in this essential sector.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.74(USD Billion) |
| MARKET SIZE 2024 | 1.88(USD Billion) |
| MARKET SIZE 2035 | 4.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.115% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Agilent Technologies, Abbott Laboratories, Roche, Thermo Fisher Scientific, PerkinElmer, QIAGEN, BristolMyers Squibb, Amgen, BioRad Laboratories, Eurofins Scientific, Merck KGaA, F. HoffmannLa Roche, SigmaAldrich, GSK, Illumina |
| SEGMENTS COVERED | Product, Profiling Technology, Application, Research Area |
| KEY MARKET OPPORTUNITIES | Personalized medicine development, Companion diagnostics advancement, Biomarker discovery for diseases, Non-invasive testing innovations, Integration with digital health technologies |
| KEY MARKET DYNAMICS | Rising prevalence of chronic diseases, Advancements in genomics and proteomics, Increasing demand for personalized medicine, Government funding and support, Growth of companion diagnostics |
| COUNTRIES COVERED | UK |
FAQs
What is the expected market size of the UK Biomarker Technologies Market in 2024?
The UK Biomarker Technologies Market is expected to be valued at 1.88 billion USD in 2024.
What will be the market value of the UK Biomarker Technologies Market in 2035?
By 2035, the market is anticipated to reach a value of 4.0 billion USD.
What is the expected CAGR for the UK Biomarker Technologies Market from 2025 to 2035?
The market is projected to grow at a CAGR of 7.115% from 2025 to 2035.
Which sub-segment of the UK Biomarker Technologies Market is expected to have the highest value in 2024?
In 2024, the consumables sub-segment is expected to be valued at 1.25 billion USD.
How much is the instruments sub-segment expected to be valued in 2035?
The instruments sub-segment is expected to be valued at 1.5 billion USD in 2035.
Who are the key players in the UK Biomarker Technologies Market?
Major players in the market include Agilent Technologies, Abbott Laboratories, and Roche.
What growth opportunities exist within the UK Biomarker Technologies Market?
Key opportunities include advancements in technology and an increasing focus on personalized medicine.
Are there any significant challenges impacting the UK Biomarker Technologies Market?
Challenges include regulatory hurdles and the complexity of biomarker validation.
What are the key applications driving growth in the UK Biomarker Technologies Market?
Key applications driving growth include drug discovery, diagnostics, and personalized medicine research.
How does the current global scenario impact the UK Biomarker Technologies Market?
The global scenario influences the market through changes in funding, research collaboration, and regulatory policies.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment